Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany

Sex Differences in Colorectal Cancer Survival: Population-Based Analysis of 164,996 Colorectal Cancer Patients in Germany

Risk of colorectal cancer (CRC) is considerably higher in men compared to women; however, there is inconclusive evidence of sex differences in CRC prognosis. We aimed to assess and explain sex differences in 5-year relative survival using standard and model-based period analysis among 164,996 patien...

Full description

Bibliographic Details
Main Authors:	Majek, Ondrej, Gondos, Adam, Jansen, Lina, Emrich, Katharina, Holleczek, Bernd, Katalinic, Alexander, Nennecke, Alice, Eberle, Andrea, Brenner, Hermann
Format:	Online
Language:	English
Published:	Public Library of Science 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702575/

Similar Items

Survival from colorectal cancer in Germany in the early 21st century
by: Majek, O, et al.
Published: (2012)

Survival of Patients with Oral Cavity Cancer in Germany
by: Listl, Stefan, et al.
Published: (2013)

Survival of endometrial cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage
by: Chen, Tianhui, et al.
Published: (2012)

Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States
by: Pulte, Dianne, et al.
Published: (2014)

A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects
by: Liu, Hao, et al.
Published: (2013)

Breast Cancer Survival in Germany: A Population-Based High Resolution Study from Saarland
by: Holleczek, Bernd, et al.
Published: (2013)

Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century
by: Pulte, Dianne, et al.
Published: (2016)

Trends of population-based breast cancer survival in Germany and the US: Decreasing discrepancies, but persistent survival gap of elderly patients in Germany
by: Holleczek, Bernd, et al.
Published: (2012)

Population level survival of patients with chronic myelocytic leukemia in Germany compared to the US in the early 21st century
by: Pulte, Dianne, et al.
Published: (2013)

Provision of breast cancer care and survival in Germany – results from a population-based high resolution study from Saarland
by: Holleczek, Bernd, et al.
Published: (2014)

Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries
by: Chen, Tianhui, et al.
Published: (2016)

Survival of patients with symptom- and screening-detected colorectal cancer
by: Brenner, Hermann, et al.
Published: (2016)

Adherence to Physician Recommendations for Surveillance in Opportunistic Colorectal Cancer Screening: The Necessity of Organized Surveillance
by: Stock, Christian, et al.
Published: (2013)

Cost-effectiveness of Colorectal Cancer Screening
by: Lansdorp-Vogelaar, Iris, et al.
Published: (2011)

Colorectal cancer screening: the time to act is now
by: Brenner, Hermann, et al.
Published: (2015)

Prostate cancer in Germany among migrants from the Former Soviet Union
by: Winkler, Volker, et al.
Published: (2012)

Estimating the number of colorectal cancer patients treated with anti-tumour therapy in 2015: the analysis of the Czech National Cancer Registry
by: Pavlík, Tomáš, et al.
Published: (2012)

Minimally Invasive Colorectal Cancer Surgery in Europe: Implementation and Outcomes
by: Babaei, Masoud, et al.
Published: (2016)

Identification and Evaluation of Plasma MicroRNAs for Early Detection of Colorectal Cancer
by: Luo, Xiaoya, et al.
Published: (2013)

Expression of oestrogen receptor β and prognosis of colorectal cancer
by: Rudolph, A, et al.
Published: (2012)

Colorectal Cancer Chemoprevention: Is This the Future of Colorectal Cancer Prevention?
by: Manzano, A., et al.
Published: (2012)

Health profiles of 996 melanoma survivors: the M. D. Anderson experience
by: Stava, Charles, et al.
Published: (2006)

Mutations in POLE and survival of colorectal cancer patients – link to disease stage and treatment
by: Stenzinger, Albrecht, et al.
Published: (2014)

Non-invasive prognostic protein biomarker signatures associated with colorectal cancer
by: Surinova, Silvia, et al.
Published: (2015)

Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study
by: Rudolph, Anja, et al.
Published: (2014)

No association of CpG island methylator phenotype and colorectal cancer survival: population-based study
by: Jia, Min, et al.
Published: (2016)

Small colorectal polyps as predecessors of colorectal cancer
by: А. К. Safiyeva, et al.
Published: (2018-07-01)

How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia?
by: Suchanek, Stepan, et al.
Published: (2016)

Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis
by: Bozorgmehr, Kayvan, et al.
Published: (2015)

Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008–2010
by: Bozorgmehr, Kayvan, et al.
Published: (2015)

Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry
by: Slavicek, Lubomir, et al.
Published: (2014)

Sugars, sucrose and colorectal cancer risk: the Fukuoka colorectal cancer study
by: Wang, Zhenjie, et al.
Published: (2014)

Smoking-associated DNA methylation markers predict lung cancer incidence
by: Zhang, Yan, et al.
Published: (2016)

Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review
by: Jia, Min, et al.
Published: (2016)

Fecal Immunochemical Tests Combined With Other Stool Tests for Colorectal Cancer and Advanced Adenoma Detection: A Systematic Review
by: Niedermaier, Tobias, et al.
Published: (2016)

PLZF Expression during Colorectal Cancer Development and in Normal Colorectal Mucosa according to Body Size, as Marker of Colorectal Cancer Risk
by: Mariani, Francesco, et al.
Published: (2013)

Subcellular phenomena in colorectal cancer
by: Mirams, Gary R.
Published: (2008)

Cetuximab in the management of colorectal cancer
by: Lenz, Heinz-Josef
Published: (2007)

FDG-PET in colorectal cancer
by: de Geus-Oei, Lioe-Fee, et al.
Published: (2006)

Is screening for colorectal cancer worthwhile?
by: Chamberlain, J.
Published: (1990)